This study clearly demonstrated that pegylated liposomal doxorubicin (lipo-dox) is an effective anti-cancer agent against the growth of HepG2 hepatoma and 18F-FLT-PET could noninvasively provide early information of tumor response during the course of treatment. We believed this modality can …